These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10037766)

  • 1. Polymer structure and solubility of deoxyhemoglobin S in the presence of high concentrations of volume-excluding 70-kDa dextran. Effects of non-s hemoglobins and inhibitors.
    Bookchin RM; Balazs T; Wang Z; Josephs R; Lew VL
    J Biol Chem; 1999 Mar; 274(10):6689-97. PubMed ID: 10037766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2,3-Diphosphoglycerate and intracellular pH as interdependent determinants of the physiologic solubility of deoxyhemoglobin S.
    Poillon WN; Kim BC
    Blood; 1990 Sep; 76(5):1028-36. PubMed ID: 2393711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced inhibition of polymerization of sickle cell hemoglobin in the presence of recombinant mutants of human fetal hemoglobin with substitutions at position 43 in the gamma-chain.
    Tam MF; Chen J; Tam TC; Tsai CH; Shen TJ; Simplaceanu V; Feinstein TN; Barrick D; Ho C
    Biochemistry; 2005 Sep; 44(36):12188-95. PubMed ID: 16142917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of alpha 114 and beta 87 amino acid residues in the polymerization of hemoglobin S: implications for gene therapy.
    Ho C; Willis BF; Shen TJ; Dazhen NT; Sun DP; Tam MF; Suzuka SM; Fabry ME; Nagel RL
    J Mol Biol; 1996 Nov; 263(3):475-85. PubMed ID: 8918602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sickle Cell Hemoglobin with Mutation at αHis-50 Has Improved Solubility.
    Tam MF; Tam TC; Simplaceanu V; Ho NT; Zou M; Ho C
    J Biol Chem; 2015 Aug; 290(35):21762-72. PubMed ID: 26187468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Hb A variant (beta73 Asp-->Leu) disrupts Hb S polymerization by a novel mechanism.
    Adachi K; Ding M; Surrey S; Rotter M; Aprelev A; Zakharov M; Weng W; Ferrone FA
    J Mol Biol; 2006 Sep; 362(3):528-38. PubMed ID: 16926024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of carbonmonoxy sickle hemoglobin in R-state conformation.
    Ghatge MS; Ahmed MH; Omar AS; Pagare PP; Rosef S; Kellogg GE; Abdulmalik O; Safo MK
    J Struct Biol; 2016 Jun; 194(3):446-50. PubMed ID: 27085422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free energy of sickle hemoglobin polymerization: a scaled-particle treatment for use with dextran as a crowding agent.
    Liu Z; Weng W; Bookchin RM; Lew VL; Ferrone FA
    Biophys J; 2008 May; 94(9):3629-34. PubMed ID: 18212015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The polymerization of nickel (II) hemoglobin S under aerobic conditions.
    Alston K; Park CM; Rodgers DW; Edelstein SJ; Nagel RL
    Blood; 1984 Aug; 64(2):556-8. PubMed ID: 6743829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of the hemoglobin concentration in deoxyhemoglobin S polymers and characterization of the polymer water compartment.
    Bookchin RM; Balazs T; Lew VL
    J Mol Biol; 1994 Nov; 244(1):100-9. PubMed ID: 7966313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymerization and solubility of recombinant hemoglobins alpha 2 beta 2 (6Val) (Hb S) and alpha 2 beta 2(6Leu) (Hb Leu).
    Adachi K; Rappaport E; Eck HS; Konitzer P; Kim J; Surrey S
    Hemoglobin; 1991; 15(5):417-30. PubMed ID: 1802884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gelling properties of apohemoglobin S alone and in mixtures with hemoglobin S.
    Campbell B; Fronticelli C; Zachary A; Bucci E
    J Biol Chem; 1986 Mar; 261(9):3931-3. PubMed ID: 3949796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct intracellular measurement of deoxygenated hemoglobin S solubility.
    Fabry ME; Desrosiers L; Suzuka SM
    Blood; 2001 Aug; 98(3):883-4. PubMed ID: 11468193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sparing effect of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S at physiologic ligand saturations.
    Poillon WN; Kim BC; Rodgers GP; Noguchi CT; Schechter AN
    Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5039-43. PubMed ID: 7685112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ionic strength dependence of the polymer solubilities of deoxyhemoglobin S + C and S + A mixtures.
    Bookchin RM; Balazs T
    Blood; 1986 Apr; 67(4):887-92. PubMed ID: 3955234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alizarin interaction with sickle hemoglobin: elucidation of their anti-sickling properties by multi-spectroscopic and molecular modeling techniques.
    Syed MM; Doshi PJ; Kulkarni MV; Dhavale DD; Kadam NS; Kate SL; Doshi JB; Sharma N; Uppuladinne M; Sonavane U; Joshi R; Doshi SJ; Bhattacharya N
    J Biomol Struct Dyn; 2019 Oct; 37(17):4614-4631. PubMed ID: 30558488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of zeta-globin substitution on the O2-transport properties of Hb S in vitro and in vivo.
    He Z; Russell JE
    Biochem Biophys Res Commun; 2004 Dec; 325(4):1376-82. PubMed ID: 15555579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of inhibition of sickling by dimethyl adipimidate. Effects of intertetramer cross-linking.
    Pennathur-Das R; Heath R; Mentzer W; Lubin B
    Biochim Biophys Acta; 1984 Dec; 791(2):259-64. PubMed ID: 6509069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 2, 3-diphosphoglycerate on the solubility of deoxy-sickle hemoglobin.
    Swerdlow PH; Bryan RA; Bertles JF; Poillon WN; Magdoff-Fairchild B; Milner PF
    Hemoglobin; 1977; 1(6):527-37. PubMed ID: 914634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A transgenic mouse model of hemoglobin S Antilles disease.
    Popp RA; Popp DM; Shinpock SG; Yang MY; Mural JG; Aguinaga MP; Kopsombut P; Roa PD; Turner EA; Rubin EM
    Blood; 1997 Jun; 89(11):4204-12. PubMed ID: 9166865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.